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Portosystemic encephalopathy is one of the most im-
portant complications of liver cirrhosis. The restoration
of normal hepatic function and the reduction of porto-
systemic shunts by means of a liver graft are followed
by the resolution of hepatic encephalopathy. We report
the case of a patient with a normal functioning graft
that developed recurrent encephalopathy after trans-
plantation. The patient was successfully treated by em-
bolization of a large portosystemic shunt between the
superior mesenteric vein and both gonadal veins, this
causing an inversion of the superior mesenteric vein
flow.
CASE REPORT
A 58-year-old male with alcoholic liver cirrhosis was
referred to our center for liver transplantation in April
2006. Liver cirrhosis had been diagnosed in October
2005, and he had remained abstinent since then. At
diagnosis, he had jaundice, edema, and ascites. De-
spite 6 months of abstinence, his Model for End-Stage
Liver Disease score at referral for transplantation was
20. Three months later, he had his first episode of
hepatic encephalopathy, with rapid improvement after
diuretic withdrawal and treatment with oral lactulose.
He had no more episodes of encephalopathy before
transplantation. In the pretransplant assessment, a
patent portal vein, with slow hepatopetal flow, was
found in a Doppler ultrasound examination. An abdom-
inal computed tomography scan showed a cirrhotic
liver without hypervascular lesions; the portal vein di-
ameter was 12 mm, and important collateral circula-
tion was found.
He underwent liver transplantation in August 2006
with a whole cadaveric graft from a 70-year-old woman.
Portal vein flow at the beginning of the surgery was 200
mL/minute; it increased to 1000 mL/minute after graft
reperfusion. His postoperative course was uneventful,
and he was discharged 6 days after transplantation. He
developed posttransplant diabetes mellitus, requiring
insulin therapy. In the following months, he had mod-
erate tremor, secondary to tacrolimus, that improved
when the tacrolimus dose was reduced. Five months
after transplantation, he had a moderate increase in
serum aminotransferase values (up to 5 times the up-
per limit of normal range). A liver biopsy showed a
moderate portal and lobular inflammatory infiltrate
and mild portal fibrosis. Liver function tests spontane-
ously improved without changes in immunosuppres-
sive therapy (tacrolimus, 4 mg/day, and prednisone,
7.5 mg/day).
Ten months after transplantation, the patient was
admitted to the hospital with a 2-day history of disori-
entation. On physical examination, the patient was dis-
oriented and had inappropriate speech; asterixis was
evident, and no sign suggestive of focal neurological
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damage was found. Serum urea, creatinine, and liver
function tests were normal. Serum ammonia levels
were 197 g/dL. A brain magnetic resonance scan did
not reveal changes when compared with a scan per-
formed before liver transplantation (T1-weighted hyper-
intensity of basal ganglia was present in both examina-
tions). Doppler ultrasound revealed patency of both the
portal vein (with a flow of 15 cm/second) and the he-
patic artery. The patient was treated with oral lactulose,
and the clinical picture improved in less than 24 hours.
An uncomplicated urinary tract infection was also di-
agnosed, and ceftriaxone treatment was indicated. He
was discharged 3 days after admission; oral lactulose
was prescribed at discharge.
Two weeks later, the patient was admitted again with
disorientation and somnolence. On physical examina-
tion, asterixis was again evident. Serum ammonia lev-
els were 202 g/dL, and liver function tests were nor-
mal. An electroencephalogram was consistent with
metabolic encephalopathy (lentification and occasional
triphasic waves). Nuclear magnetic resonance spectros-
copy revealed a marked glutamine increase and a de-
crease in myo-inositol suggestive of hepatic encepha-
lopathy.1 A urine culture was negative, and the patient
did not have any other apparent cause or precipitant of
this episode of encephalopathy.
With the aim of detecting occult portosystemic collat-
erals, abdominal angiography was performed. The ve-
nous phase of the superior mesenteric arteriogram
showed that the venous return from jejunal, ileal, and
colonic veins was deviated to gross varices draining to
inferior vena cava (Fig. 1). The splenic angiography
showed that a large proportion of venous flow was sto-
len from the superior mesenteric vein to the previously
mentioned varices (Fig. 2). A retrospective examination
of the abdominal computed tomography scan per-
formed before transplantation showed the presence of
huge collaterals in the retroperitoneum (Retzius veins)2
that connected these varices to both gonadal veins and
a large left renal vein (Fig. 3).
Embolization of these collateral veins was decided
and then performed; bilateral femoral vein access was
used. After catheterization of the left femoral vein, a
catheter was introduced through the left gonadal vein,
which received its flow from a large-caliber tortuous
retroperitoneal collateral. In parallel with this catheter,
a second catheter was advanced, and the flow was sub-
Figure 1. Late venous phase of a superior mesenteric arte-
riogram. The superior mesenteric vein is not opacified. The
flow is diverted toward large collateral veins (arrows).
Figure 2. Late venous phase of a splenic arteriogram. There
is hepatofugal flow toward the superior mesenteric vein (ar-
rowhead). The flow is diverted toward large collateral veins
(arrows).
Figure 3. Computed tomography performed before liver
transplantation. Collaterals in the territory of the left gonadal
vein are clearly depicted (arrow). An enlarged right gonadal
vein can also be seen (arrowhead).
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sequently stopped. Segments of mobile core guide and
different caliber coils were used to completely occlude
the left shunt (Fig. 4). Afterwards, the right gonadal vein
was catheterized and completely occluded with several
coils and two 12-mm occluding Amplatzer devices
(Fig. 5).
One month later, a new angiogram from the superior
mesenteric artery showed that venous mesenteric vein
flow was patent and hepatopetal and that there was no
flow to varices or collateral veins (Fig. 6). The venous
phase of a splenic angiograph showed the absence of
reverse flow directed toward the superior mesenteric
artery (Fig. 7). Ten months after the embolization, the
patient remains free of new episodes of encephalopa-
thy.
DISCUSSION
Hepatic encephalopathy is usually a complication of
acute and chronic liver disease, but it has also been
reported in patients with major portosystemic shunts
without cirrhosis.3 In patients with liver cirrhosis, the
restoration of normal liver function after liver trans-
plantation is usually followed by the resolution of en-
cephalopathy, despite the persistence of portosystemic
shunts. In the case reported here, the development of
hepatic encephalopathy was unexpected because graft
function was normal. High ammonia levels, electroen-
cephalogram changes, improvement with lactulose and
magnetic resonance spectroscopy, and the exclusion of
other structural or metabolic causes strongly suggest
that the clinical picture was consistent with hepatic
encephalopathy related to the presence of such shunts.
Finally, the absence of new episodes of encephalopathy
after their embolization confirmed that suspicion.
In liver transplant recipients, large collateral veins
may steal flow from the portal vein because they may
remain patent even with a very low portosystemic pres-
Figure 4. Left gonadal vein phlebography performed after its
embolization with coils and segments of guide wire. An occlu-
sion balloon catheter (still inflated) is seen (arrow).
Figure 5. Right gonadal vein phlebography performed after
its embolization with coils and Amplatzers (arrow).
Figure 6. Late venous phase of a superior mesenteric arte-
riogram. The superior mesenteric vein is now opacified and
presents hepatopetal flow.
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sure gradient. These collateral veins may reduce portal
flow through a competitive flow-steal phenomenon,
thus precipitating portal vein thrombosis.4 Large spon-
taneous portosystemic shunts may also have a detri-
mental effect on graft function.5 In patients with cirrho-
sis and hepatic encephalopathy, it has been previously
reported that the occlusion of portosystemic shunts
improves this condition.6 Thus, in liver transplant can-
didates, the occlusion of portosystemic shunts would
ameliorate hepatic encephalopathy and avoid all these
aforementioned risks. Unfortunately, the closure of
these shunts could lead to esophageal or gastric
variceal bleeding.7 This complication is not expected in
liver transplant recipients with a normal grafted liver.
Therefore, a potential approach to this problem could
be the intraoperative ligation or embolization of these
shunts in the immediate postoperative period. In a re-
cent article, Aucejo et al.8 suggested that triple-phase
computed tomography should be used for characteriz-
ing these portosystemic shunts. They also recom-
mended measuring intraoperative portal vein flow. If
postreperfusion portal vein flow is less than 1
L/minute, shunt ligation should be indicated to avoid
the risk of postoperative portal vein thrombosis.8
Portosystemic shunts, although detected in sectional
studies (computed tomography or magnetic resonance),
should be evaluated by conventional angiography,
which allows not only their demonstration but also the
recognition of their precise routes of connection. When
identified, they can be embolized, as demonstrated in
this case, with specific methods such as the use of
large-caliber occluding devices (Amplatzer or wire seg-
ments) or the reduction of their flow with simultaneous
occluding techniques (balloon catheters).9
In conclusion, large portosystemic shunts may per-
sist after liver transplantation in patients with cirrhosis
if they are not ligated during transplant surgery. These
shunts may allow the development of hepatic enceph-
alopathy in the absence of significant liver damage.
Embolization of these shunts is a potential and effective
treatment for this condition.
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Figure 7. Late venous phase of a splenic arteriogram. There
is no hepatofugal flow toward the superior mesenteric vein.
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